| Business Name: |
Astute Medical Inc |
| Contact Person: |
Chris Hibberd, President |
| Address: |
3550 General Atomics Court, San Diego, California 92121 |
| Phone Number: |
(858) 792-3544 |
| Website Address: |
us.astutemedical.com |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Founding Year: |
2007 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Commercial Medical Research |
| SIC Code: |
8731 |
| NAICS Code: |
6213400 |
| Share This Business: |
|
| Related Businesses: |
Medivas LLC - San Diego, CA 92121
Bio-Quant Inc - San Diego, CA 92121
Cylene Pharmaceuticals - San Diego, CA 92121
Krex Pharmaceuticals Inc - San Diego, CA 92121
Advanced Biodelivery Sciences - San Diego, CA 92121
S K S Ocular LLC - San Diego, CA 92121
Tenova Pharmaceuticals Inc - San Diego, CA 92121
Stemedica Cell Technology - San Diego, CA 92121
Gnf Commercial Systems - San Diego, CA 92121
Sage Bioventures Inc - San Diego, CA 92121
Rempex Pharmaceuticals Inc - San Diego, CA 92121
Biomedica Inc - San Diego, CA 92121
Helicon Therapeutics - San Diego, CA 92121
Celgene Research San Diego - San Diego, CA 92121
Targegen Inc - San Diego, CA 92121
Acea Biosciences Inc - San Diego, CA 92121
|
The company Astute Medical Inc provides B2B services in the form of Commercial Medical Research from its single location in California.
1 to 4 employees work for Astute Medical Inc, and the business now earns $500.000 to $999.999 per annum.
Astute Medical Inc was launched in 2007 and is classified under SIC code and category 8731 , and NAICS number and grouping 6213400 .
To contact Astute Medical Inc, please call Chris Hibberd, President with the phone number (858) 792-3544 or visit its single location at 3550 General Atomics Court in San Diego, California 92121.
The location of the single location can also be found using the coordinates 32.89416,-117.2372.
Read more details about this business on the webpage us.astutemedical.com or follow the company’s social media accounts, on Twitter and on Facebook.